← FDA Drug Approvals (Drugs@FDA)

OMONTYS

NDA · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2012-03-27

Drug application

FDA Application #

NDA202799

Application type

New Drug Application

Brand name

OMONTYS

Generic name

Peginesatide Acetate

Active ingredients

PEGINESATIDE ACETATE

Dosage form

SOLUTION

Route

INTRAVENOUS, SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

TAKEDA PHARMS USA

First approval

2012-03-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown